FOXN4
gene geneOn this page
Summary
FOXN4 (forkhead box N4, HGNC:21399) is a protein-coding gene on chromosome 12q24.11, encoding Forkhead box protein N4 (Q96NZ1). Transcription factor essential for neural and some non-neural tissues development, such as retina and lung respectively.
Members of the winged-helix/forkhead family of transcription factors, such as FOXN4, are characterized by a 110-amino acid DNA-binding domain that can fold into a variant of the helix-turn-helix motif consisting of 3 alpha helices flanked by 2 large loops or wings. These transcription factors are involved in a variety of biologic processes as key regulators in development and metabolism (Li et al., 2004 [PubMed 15363391]).
Source: NCBI Gene 121643 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 79 total
- MANE Select transcript:
NM_213596
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21399 |
| Approved symbol | FOXN4 |
| Name | forkhead box N4 |
| Location | 12q24.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000139445 |
| Ensembl biotype | protein_coding |
| OMIM | 609429 |
| Entrez | 121643 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 nonsense_mediated_decay
ENST00000299162, ENST00000355216, ENST00000423960, ENST00000468516
RefSeq mRNA: 1 — MANE Select: NM_213596
NM_213596
CCDS: CCDS9126
Canonical transcript exons
ENST00000299162 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000938176 | 109287397 | 109287524 |
| ENSE00000997899 | 109288056 | 109288180 |
| ENSE00001100117 | 109287844 | 109287954 |
| ENSE00001475300 | 109290141 | 109290286 |
| ENSE00001909721 | 109277978 | 109279930 |
| ENSE00003646855 | 109285304 | 109285511 |
| ENSE00003657060 | 109308236 | 109308324 |
| ENSE00003664119 | 109286648 | 109286744 |
| ENSE00003681766 | 109281407 | 109281799 |
| ENSE00003845146 | 109309119 | 109309284 |
Expression profiles
Bgee: expression breadth ubiquitous, 104 present calls, max score 84.94.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1617 / max 16.2764, expressed in 83 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 133188 | 0.0588 | 29 |
| 133189 | 0.0573 | 34 |
| 133187 | 0.0456 | 20 |
Top tissues by expression
229 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 84.94 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.37 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.04 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.64 | gold quality |
| left testis | UBERON:0004533 | 76.61 | gold quality |
| right testis | UBERON:0004534 | 76.15 | gold quality |
| testis | UBERON:0000473 | 74.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.28 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 71.71 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 70.80 | gold quality |
| sperm | CL:0000019 | 68.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 67.27 | gold quality |
| gingiva | UBERON:0001828 | 66.37 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 66.21 | gold quality |
| secondary oocyte | CL:0000655 | 65.94 | gold quality |
| oocyte | CL:0000023 | 65.58 | gold quality |
| myocardium | UBERON:0002349 | 64.99 | gold quality |
| cardia of stomach | UBERON:0001162 | 64.77 | gold quality |
| superficial temporal artery | UBERON:0001614 | 64.64 | gold quality |
| vastus lateralis | UBERON:0001379 | 64.53 | gold quality |
| quadriceps femoris | UBERON:0001377 | 64.46 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 64.42 | gold quality |
| deltoid | UBERON:0001476 | 64.21 | gold quality |
| cortical plate | UBERON:0005343 | 64.19 | gold quality |
| superior surface of tongue | UBERON:0007371 | 63.79 | gold quality |
| saphenous vein | UBERON:0007318 | 63.55 | gold quality |
| tongue | UBERON:0001723 | 63.49 | gold quality |
| pericardium | UBERON:0002407 | 63.49 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 63.32 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 63.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.43 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
8 targets.
| Target | Regulation |
|---|---|
| ASCL1 | Unknown |
| DLL4 | Activation |
| NEUROD1 | Activation |
| NEUROD4 | Activation |
| NR4A2 | Unknown |
| PANK2 | Unknown |
| PROX1 | Activation |
| PTF1A | Activation |
Upstream regulators (CollecTRI, top): MEIS1
miRNA regulators (miRDB)
59 targeting FOXN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-182-3P | 99.57 | 67.57 | 825 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-501-3P | 99.33 | 66.12 | 651 |
| HSA-MIR-502-3P | 99.33 | 66.12 | 651 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-3922-3P | 99.25 | 64.96 | 1136 |
Literature-anchored findings (GeneRIF, showing 1)
- FOXN4 affects myocardial ischemia-reperfusion injury through HIF-1alpha/MMP2-mediated ferroptosis of cardiomyocytes. (PMID:37605566)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | foxn4 | ENSDARG00000010591 |
| mus_musculus | Foxn4 | ENSMUSG00000042002 |
| rattus_norvegicus | Foxn4 | ENSRNOG00000000691 |
Paralogs (2): FOXN3 (ENSG00000053254), FOXN2 (ENSG00000170802)
Protein
Protein identifiers
Forkhead box protein N4 — Q96NZ1 (reviewed: Q96NZ1)
All UniProt accessions (3): A0A0C4DG65, Q96NZ1, S4R3U5
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor essential for neural and some non-neural tissues development, such as retina and lung respectively. Binds to an 11-bp consensus sequence containing the invariant tetranucleotide 5’-ACGC-3’. During development of the central nervous system, is required to specify the amacrine and horizontal cell fates from multipotent retinal progenitors while suppressing the alternative photoreceptor cell fates through activating DLL4-NOTCH signaling. Also acts synergistically with ASCL1/MASH1 to activate DLL4-NOTCH signaling and drive commitment of p2 progenitors to the V2b interneuron fates during spinal cord neurogenesis. In development of non-neural tissues, plays an essential role in the specification of the atrioventricular canal and is indirectly required for patterning the distal airway during lung development.
Subcellular location. Nucleus.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96NZ1-1 | 1 | yes |
| Q96NZ1-2 | 2 | |
| Q96NZ1-3 | 3 |
RefSeq proteins (1): NP_998761* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR030456 | TF_fork_head_CS_2 | Conserved_site |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR047119 | FOXN2/3-like | Family |
Pfam: PF00250
UniProt features (9 total): splice variant 4, region of interest 2, chain 1, DNA-binding region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NZ1-F1 | 58.22 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 100 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_NEUROGENESIS, GOBP_NEURAL_RETINA_DEVELOPMENT, GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD, GOBP_DORSAL_VENTRAL_PATTERN_FORMATION, GOBP_SPECIFICATION_OF_SYMMETRY, GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT, GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS, GOBP_HEART_MORPHOGENESIS, GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION
GO Biological Process (11): heart looping (GO:0001947), regulation of DNA-templated transcription (GO:0006355), regulation of heart contraction (GO:0008016), retina layer formation (GO:0010842), ventral spinal cord interneuron differentiation (GO:0021514), amacrine cell differentiation (GO:0035881), atrioventricular canal development (GO:0036302), positive regulation of transcription by RNA polymerase II (GO:0045944), ventral spinal cord interneuron fate commitment (GO:0060579), nervous system development (GO:0007399), neuron fate commitment (GO:0048663)
GO Molecular Function (7): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), cis-regulatory region sequence-specific DNA binding (GO:0000987), chromatin binding (GO:0003682), DNA-binding transcription factor activity (GO:0003700), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| neural retina development | 2 |
| central nervous system neuron differentiation | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription cis-regulatory region binding | 2 |
| binding | 2 |
| embryonic heart tube morphogenesis | 1 |
| determination of heart left/right asymmetry | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| heart contraction | 1 |
| regulation of blood circulation | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| retina morphogenesis in camera-type eye | 1 |
| cell differentiation in spinal cord | 1 |
| ventral spinal cord development | 1 |
| heart development | 1 |
| anatomical structure development | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| spinal cord dorsal/ventral patterning | 1 |
| ventral spinal cord interneuron differentiation | 1 |
| neuron fate commitment | 1 |
| cell fate commitment involved in pattern specification | 1 |
| system development | 1 |
| neuron differentiation | 1 |
| cell fate commitment | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1328 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXN4 | NEUROD4 | Q9HD90 | 936 |
| FOXN4 | NEUROD1 | Q13562 | 859 |
| FOXN4 | PROX1 | Q92786 | 808 |
| FOXN4 | PTF1A | Q7RTS3 | 734 |
| FOXN4 | VSX2 | P58304 | 689 |
| FOXN4 | VSX1 | Q9NZR4 | 666 |
| FOXN4 | ATOH7 | Q8N100 | 665 |
| FOXN4 | BARHL2 | Q9NY43 | 632 |
| FOXN4 | POU4F2 | Q12837 | 588 |
| FOXN4 | BHLHE22 | Q8NFJ8 | 542 |
| FOXN4 | CRX | O43186 | 528 |
| FOXN4 | PAX6 | P26367 | 518 |
| FOXN4 | ASCL1 | P50553 | 492 |
| FOXN4 | DLL4 | Q9NR61 | 487 |
| FOXN4 | ISL1 | P20663 | 464 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RFX2 | FOXN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATXN1 | FOXN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXN4 | AMY1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL3 | FOXN4 | psi-mi:“MI:0915”(physical association) | 0.490 |
| FOXN4 | FHL3 | psi-mi:“MI:0915”(physical association) | 0.490 |
| EGLN3 | FAM168B | psi-mi:“MI:0914”(association) | 0.350 |
| FOXN4 | GABARAP | psi-mi:“MI:0914”(association) | 0.350 |
| ATXN1 | FOXN4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXN4 | RFX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RFX2 | FOXN4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): AMY1C (Affinity Capture-MS), GABARAP (Affinity Capture-MS), FOXN4 (Affinity Capture-MS), FOXN4 (Two-hybrid), FOXN4 (Two-hybrid), FOXN4 (Two-hybrid), AMY1C (Affinity Capture-MS), LMBRD1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1L8H0H2, A2BGM5, A3KNJ3, F1QDF8, F1R8Z9, F8VPJ6, O00409, O75030, P59667, P70056, P79269, Q08050, Q1KKS7, Q1KL10, Q28D67, Q28EM1, Q28EW4, Q28GC4, Q2KHR2, Q32NH9, Q33BP8, Q3BJS1, Q3UHX8, Q499D0, Q4G112, Q503Z8, Q5M7N6, Q5W1J6, Q5WM45, Q61321, Q66IG8, Q68EZ2, Q6NVT7, Q708W1, Q708W2, Q7T1C0, Q8AWZ2, Q8IVH2, Q8K3Q3, Q91904
Diamond homologs: A0A8V0YY16, A1L1S5, A2BGM5, A8MTJ6, B5RHS5, D3Z120, O00358, O00409, O15353, O54743, O60129, O70220, O88470, O93529, P32027, P32028, P32030, P32314, P42128, P55316, P56260, P58012, Q00939, Q12946, Q12947, Q12948, Q12951, Q13461, Q1A1A1, Q1A1A2, Q1A1A3, Q1A1A4, Q1A1A5, Q1A1A6, Q28BS5, Q28D67, Q28F43, Q28G71, Q28H65, Q28HT3
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| FOXN4 | “up-regulates quantity by expression” | PTF1A | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
79 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1091 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:109281405:AC:A | donor_gain | 1.0000 |
| 12:109281406:CC:C | donor_gain | 1.0000 |
| 12:109285320:C:CA | donor_gain | 1.0000 |
| 12:109285343:T:TA | donor_gain | 1.0000 |
| 12:109285507:GCCGT:G | acceptor_gain | 1.0000 |
| 12:109285508:CCGT:C | acceptor_gain | 1.0000 |
| 12:109285508:CCGTC:C | acceptor_gain | 1.0000 |
| 12:109285509:CGT:C | acceptor_gain | 1.0000 |
| 12:109285509:CGTC:C | acceptor_gain | 1.0000 |
| 12:109285510:GT:G | acceptor_gain | 1.0000 |
| 12:109285512:C:CC | acceptor_gain | 1.0000 |
| 12:109285512:C:CG | acceptor_loss | 1.0000 |
| 12:109285513:T:C | acceptor_loss | 1.0000 |
| 12:109286643:CTCA:C | donor_loss | 1.0000 |
| 12:109286644:TCACC:T | donor_loss | 1.0000 |
| 12:109286645:CACC:C | donor_loss | 1.0000 |
| 12:109286646:A:AC | donor_gain | 1.0000 |
| 12:109286647:C:CA | donor_loss | 1.0000 |
| 12:109286647:C:CC | donor_gain | 1.0000 |
| 12:109286742:CAG:C | acceptor_gain | 1.0000 |
| 12:109287542:C:CT | acceptor_gain | 1.0000 |
| 12:109287543:A:T | acceptor_gain | 1.0000 |
| 12:109287552:G:C | acceptor_gain | 1.0000 |
| 12:109287552:G:GC | acceptor_gain | 1.0000 |
| 12:109290136:CCTA:C | donor_loss | 1.0000 |
| 12:109290139:A:AG | donor_loss | 1.0000 |
| 12:109290140:C:A | donor_loss | 1.0000 |
| 12:109290191:G:A | donor_gain | 1.0000 |
| 12:109309115:GTAC:G | donor_loss | 1.0000 |
| 12:109309117:AC:A | donor_loss | 1.0000 |
AlphaMissense
3366 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:109285400:C:G | A269P | 1.000 |
| 12:109285401:C:A | W268C | 1.000 |
| 12:109285401:C:G | W268C | 1.000 |
| 12:109285402:C:G | W268S | 1.000 |
| 12:109285403:A:G | W268R | 1.000 |
| 12:109285403:A:T | W268R | 1.000 |
| 12:109285446:C:A | K253N | 1.000 |
| 12:109285446:C:G | K253N | 1.000 |
| 12:109285448:T:C | K253E | 1.000 |
| 12:109285452:G:C | F251L | 1.000 |
| 12:109285452:G:T | F251L | 1.000 |
| 12:109285453:A:C | F251C | 1.000 |
| 12:109285453:A:G | F251S | 1.000 |
| 12:109285454:A:C | F251V | 1.000 |
| 12:109285454:A:G | F251L | 1.000 |
| 12:109285454:A:T | F251I | 1.000 |
| 12:109285465:A:G | L247P | 1.000 |
| 12:109285471:A:C | L245R | 1.000 |
| 12:109285471:A:G | L245P | 1.000 |
| 12:109285471:A:T | L245Q | 1.000 |
| 12:109285473:G:C | N244K | 1.000 |
| 12:109285473:G:T | N244K | 1.000 |
| 12:109285474:T:A | N244I | 1.000 |
| 12:109285475:T:C | N244D | 1.000 |
| 12:109285476:G:C | H243Q | 1.000 |
| 12:109285476:G:T | H243Q | 1.000 |
| 12:109285477:T:A | H243L | 1.000 |
| 12:109285477:T:C | H243R | 1.000 |
| 12:109285477:T:G | H243P | 1.000 |
| 12:109285478:G:A | H243Y | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000034527 (12:109290698 A>T), RS1000057991 (12:109284644 G>A), RS1000206568 (12:109308504 G>A), RS1000237766 (12:109307989 A>C), RS1000286606 (12:109284398 G>C,T), RS1000360540 (12:109284109 C>T), RS1000542592 (12:109310446 G>A), RS1000563433 (12:109308389 A>C), RS1000571985 (12:109309664 G>A), RS1000700778 (12:109282580 C>T), RS1000838845 (12:109288346 T>A), RS1001035416 (12:109303364 C>G,T), RS1001129228 (12:109290591 C>T), RS1001244868 (12:109300932 G>A), RS1001329226 (12:109284151 A>G)
Disease associations
OMIM: gene MIM:609429 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006941_4 | Irritable mood | 1.000000e-09 |
| GCST006951_4 | Feeling hurt | 9.000000e-10 |
| GCST010135_11 | Oily fish consumption | 6.000000e-11 |
| GCST010135_3 | Oily fish consumption | 7.000000e-17 |
| GCST010140_3 | Pork consumption | 6.000000e-11 |
| GCST010140_47 | Pork consumption | 7.000000e-17 |
| GCST010142_62 | Fish- and plant-related diet | 4.000000e-13 |
| GCST010142_83 | Fish- and plant-related diet | 4.000000e-08 |
| GCST010142_87 | Fish- and plant-related diet | 2.000000e-19 |
| GCST010142_94 | Fish- and plant-related diet | 5.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009594 | irritability measurement |
| EFO:0009599 | feeling emotionally hurt measurement |
| EFO:0008111 | diet measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | affects binding, increases reaction, increases expression | 2 |
| propionaldehyde | increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| pentanal | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Aldehydes | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| DEET | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Methylcholanthrene | increases expression, affects binding, increases reaction | 1 |
| Phenobarbital | affects expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Zinc Sulfate | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.